Sulfonylureas (SUs) are a class of medications used to treat type 2 diabetes mellitus that work by increasing insulin secretion in the pancreas. Second-generation SUs are most often used today because of adverse effects with those in the first generation. However, there is still a risk of hypoglycemia even with the newer medications in the class. The American Diabetes Association encourages a patient-centered approach when initiating pharmacologic therapy. Understanding the pharmacokinetic differences among these medications can allow the consultant pharmacist to make a decision on which medication may be best suited for the patient.

Download full-text PDF

Source
http://dx.doi.org/10.4140/TCP.n.2015.116.DOI Listing

Publication Analysis

Top Keywords

review safety
4
safety considerations
4
considerations elderly
4
elderly sulfonylureas
4
sulfonylureas sulfonylureas
4
sulfonylureas sus
4
sus class
4
class medications
4
medications treat
4
treat type
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!